Ticker: QBTS

D-Wave Quantum (QBTS)

Software Technology Computer Hardware
Price 16.21
Reco Sell Potential 30 Risk 74 Updated 2026-07-27

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

D-Wave Quantum specializes in quantum computing technology, offering products and services that enable businesses to solve complex problems through quantum algorithms. Its core offerings include quantum processors and software tools designed for optimization, machine learning, and simulation tasks. The company primarily generates revenue from licensing its quantum computing platforms and providing cloud-based access to its technology, targeting sectors such as finance, logistics, and pharmaceuticals.

Investment Profile

The investment profile of D-Wave Quantum is more aligned with growth investors, given its focus on innovative technology and potential market expansion. The company does not currently provide dividends, and its financial metrics suggest a higher risk profile. Investors may find it suitable for medium to long-term horizons, considering the volatility and growth potential associated with emerging technologies.

Fundamental metrics (experimental) Updated: 2026-07-27
EPS (TTM) — earnings per share for the last 12 months, $
-1.15
Revenue QoQ — quarter-over-quarter revenue growth
3.9%
EPS surprise
37.5%
20d volatility
3.4%
AI recommendation changes
Date Before After Reason
2026-06-27 Hold Sell Weak fundamentals and high volatility raise concerns.
2026-05-10 Sell Hold Weak fundamentals and high volatility raise concerns.
2026-05-08 Sell scenario_deterioration
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-15 Mizuho Securities Target Raised — → 35 23.37
2026-06-02 Stifel Nicolaus Update — → 35 29.18
2026-05-13 Canaccord Genuity Target Lowered 43 → 41 22.34
News Page 1 of 1
D-Wave Quantum (QBTS) Rigetti Computing Alexandria Real Estate American Tower

Biotech and Real Estate Sectors Show Mixed Performance Ahead of Key Oncology Meeting

The upcoming meeting of the American Society of Clinical Oncology is poised to influence biotech stocks, which have shown significant gains over the past year despite recent fluctuations. Additionally, a substantial government investment in quantum computing has sparked notable stock increases in that sector.